# Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.

Study · id `cardio:ct-nct06597201` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06597201](<https://clinicaltrials.gov/study/NCT06597201>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06597201

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT06597201. Randomized; no masking; primary purpose treatment. Start 2024-08-09 (actual); primary completion 2025-06-29 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT06597201, source copy `cardio:ctgov-nct06597201-2024-12-30`, retrieved 2026-10-26)
- Started: 2024-08-09 (actual) (ClinicalTrials.gov record NCT06597201, source copy `cardio:ctgov-nct06597201-2024-12-30`, retrieved 2026-10-26)
- Primary completion: 2025-06-29 (anticipated) (ClinicalTrials.gov record NCT06597201, source copy `cardio:ctgov-nct06597201-2024-12-30`, retrieved 2026-10-26)
- Completion: 2025-06-29 (anticipated) (ClinicalTrials.gov record NCT06597201, source copy `cardio:ctgov-nct06597201-2024-12-30`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06597201, source copy `cardio:ctgov-nct06597201-2024-12-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06597201-2024-12-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
- Condition: End Stage Renal Disease (ESRD)
- Intervention (Drug): amino acid (15) peritoneal dialysis solution
- Intervention (Drug): glucose peritoneal dialysis solution
- Lead sponsor: Chengdu Qingshan Likang Pharmaceutical Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 83e8004ae2f79b415f8cdc82c0004d6324b55fc09c96982e43f12051b1c5e6df
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
